COMMUNIQUÉ DE PRESSE
News
-
-
COMMUNIQUÉ DE PRESSE
Torq Announces Proposed US$48 Million Earn-In Option and Joint Venture Agreement with Gold Fields on Santa Cecilia Project
Torq Resources Inc. announces non-binding term sheet with Gold Fields for Santa Cecilia copper-gold project in Chile. Proposed option agreement to advance exploration & development -
-
-
-
-
COMMUNIQUÉ DE PRESSE
Immunic, Inc. to Announce Financial Results for the Second Quarter Ended June 30, 2024, and Provide Corporate Update
Immunic, Inc. to announce Q2 2024 financial results and corporate update on August 8, 2024, including webcast participation details. Company developing therapies for inflammatory diseases -
COMMUNIQUÉ DE PRESSE
Moderna Reports Second Quarter 2024 Financial Results and Provides Business Updates
Moderna, Inc. reports Q2 revenues of $241 million, GAAP net loss of $1.3 billion. Updates 2024 financial framework and expects product sales of $3.0-$3.5 billion. Announces key developments in vaccines and financial results -
COMMUNIQUÉ DE PRESSE
Zomedica to Report Second Quarter 2024 Financial Results and Provide Business Update on August 14 at 4:30 p.m. ET
Zomedica Corp. to host a conference call on August 14, 2024, at 4:30 p.m. ET to discuss Q2 2024 financial results. The company provides veterinary health products for animals -
COMMUNIQUÉ DE PRESSE
"NanoViricides Broad Spectrum Technology Represents Potential Paradigm Shift In Viral Therapy"; "Novel Anti-Viral Could Boost a US$3 Billion Market" - Conclude Two Independent Research Reports on NanoViricides
NanoViricides, Inc., reports on independent research highlighting NV-387's broad-spectrum action in viral therapy, potentially revolutionizing antiviral treatment strategies
